Sheng Chen
Impact in
- Rheumatology top 2%
- Osteoarthritis Treatment and Mechanisms
- Pharmacology top 2%
- Musculoskeletal pain and rehabilitation
- Inflammatory mediators and NSAID effects
Papers in
- Rheumatology 14
- Osteoarthritis Treatment and Mechanisms 8
- Pharmacology 11
- Inflammatory mediators and NSAID effects 6
Sheng Chen
51 papers receiving 2.3k citations
Hit Papers
Peers
Comparison fields: 5 of 129
- Rheumatology 569
- Pharmacology 574
- Pathology and Forensic Medicine 397
- Cancer Research 261
- Cell Biology 215
Countries citing papers authored by Sheng Chen
This map shows the geographic impact of Sheng Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheng Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheng Chen more than expected).
Fields of papers citing papers by Sheng Chen
This network shows the impact of papers produced by Sheng Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheng Chen. The network helps show where Sheng Chen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sheng Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2025 | 2 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 4 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 0 | |
| 7 | 2024 | 6 | |
| 8 | 2024 | 3 | |
| 9 | 2024 | 0 | |
| 10 | 2023 | 9 | |
| 11 | 2023 | 10 | |
| 12 | 2023 | 1 | |
| 13 | 2021 | 155 | |
| 14 | Global, regional and national burden of low back pain 1990–2019: A systematic analysis of the Global Burden of Disease study 2019 Hit paper breakdown → | 2021 | 254 |
| 15 | 2020 | 70 | |
| 16 | 2020 | 22 | |
| 17 | 2019 | 17 | |
| 18 | 2018 | 20 | |
| 19 | 2017 | 12 | |
| 20 | 2010 | 90 |
About Sheng Chen
Sheng Chen is a scholar working on Rheumatology, Pharmacology, Pathology and Forensic Medicine, Orthopedics and Sports Medicine and Oncology, having authored 56 papers that have together received 2.3k indexed citations. Recurring topics across this work include Osteoarthritis Treatment and Mechanisms (8 papers), Spine and Intervertebral Disc Pathology (7 papers), Inflammatory mediators and NSAID effects (6 papers), Epigenetics and DNA Methylation (4 papers), Chemokine receptors and signaling (4 papers), Autophagy in Disease and Therapy (4 papers), Cytokine Signaling Pathways and Interactions (4 papers) and MicroRNA in disease regulation (3 papers). The work is most often cited by research in Rheumatology (569 citations), Pharmacology (574 citations), Pathology and Forensic Medicine (397 citations), Cancer Research (261 citations) and Cell Biology (215 citations). Sheng Chen has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Guozhi Xiao, Xiaohao Wu, Chu Tao, Tailin He, Minghao Qu, Qing Yao, Yiming Zhong, Weiyuan Gong, Huiling Cao and Mingjue Chen. Their work appears in journals such as Journal of Orthopaedic Translation, Bone Research, International Immunopharmacology, Oxidative Medicine and Cellular Longevity and Virus Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.